Cellular senescence in human liver under normal aging and cancer.
Cellular senescence, a stress-induced program causing stable cell-cycle arrest, is a hallmark of liver aging, fibrosis, and cancer.
APA
Karpova A, Li X, et al. (2026). Cellular senescence in human liver under normal aging and cancer.. Cell genomics, 6(2), 101133. https://doi.org/10.1016/j.xgen.2025.101133
MLA
Karpova A, et al.. "Cellular senescence in human liver under normal aging and cancer.." Cell genomics, vol. 6, no. 2, 2026, pp. 101133.
PMID
41576948
Abstract
Cellular senescence, a stress-induced program causing stable cell-cycle arrest, is a hallmark of liver aging, fibrosis, and cancer. However, the cell-type-specific mechanisms, spatial organization, and cancer-associated alterations in the liver remain unclear. We profiled 43 normal human livers spanning ages and fibrosis stages using a single-cell multiome, Xenium spatial transcriptomics, and CODEX, complemented by fibrotic mouse models and 24 colorectal cancer liver metastases. We found CDKN1A+ senescent hepatocytes, fibroblasts, cholangiocytes, and endothelial cells associated with age, liver disease, or cancer. Senescence differed between aged and fibrotic livers, with similar patterns in mice. Spatially, CDKN1A+ hepatocytes localized periportally, while SERPINE1+ aging-associated hepatocytes formed spatial clusters, potentially mediated by Claudins and THBS1. Fibrotic regions contained CXCL12+ senescent fibroblasts interacting with CXCR4+ immune cells. Chemotherapy intensified senescence in hepatocytes by 5-fold relative to aging and led to unique CDKN2A+ populations. Across conditions, senescent cells shared AP-1 activation, pro-inflammatory cytokines, and apoptosis resistance, suggesting therapeutic opportunities.
MeSH Terms
Humans; Cellular Senescence; Liver; Hepatocytes; Aging; Mice; Animals; Liver Neoplasms; Male; Liver Cirrhosis; Female; Fibroblasts; Plasminogen Activator Inhibitor 1; Cyclin-Dependent Kinase Inhibitor p21; Aged; Middle Aged